Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Would homegrown LEN cost more? Why SA should still make the HIV prevention jab

South Africa aims to manufacture the revolutionary six-monthly HIV prevention injection lenacapavir locally. Experts weigh the need for rapid, affordable access against building long-term regional production capacity.

Would homegrown LEN cost more? Why SA should still make the HIV prevention jab

We haven't written up this one. Mail and Guardian has the full story — the link below goes straight to it.

Read the original at mg.co.za →

More in Health & Medicine

More from Monday 5 October →